| pubmed-article:20510551 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20510551 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:20510551 | lifeskim:mentions | umls-concept:C0524662 | lld:lifeskim |
| pubmed-article:20510551 | lifeskim:mentions | umls-concept:C0011892 | lld:lifeskim |
| pubmed-article:20510551 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20510551 | lifeskim:mentions | umls-concept:C0025605 | lld:lifeskim |
| pubmed-article:20510551 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:20510551 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:20510551 | pubmed:dateCreated | 2010-8-30 | lld:pubmed |
| pubmed-article:20510551 | pubmed:abstractText | There is consistent evidence showing women access treatment with more severe substance-related profiles relative to men; however, treatment outcome evaluation shows inconclusive results regarding gender differences. Furthermore, few studies evaluate response by gender. | lld:pubmed |
| pubmed-article:20510551 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20510551 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20510551 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20510551 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20510551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20510551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20510551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20510551 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20510551 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20510551 | pubmed:issn | 1879-0046 | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:SchechterMart... | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:MarshDavidD | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:AnisAslamA | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:KrauszMichael... | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:Oviedo-Joekes... | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:BrissetteSuza... | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:GuhDaphneD | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:NosykBohdanB | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:ChettiarJillJ | lld:pubmed |
| pubmed-article:20510551 | pubmed:author | pubmed-author:MarchandKirst... | lld:pubmed |
| pubmed-article:20510551 | pubmed:copyrightInfo | Copyright 2010 Elsevier Ireland Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:20510551 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20510551 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:20510551 | pubmed:volume | 111 | lld:pubmed |
| pubmed-article:20510551 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20510551 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20510551 | pubmed:pagination | 50-7 | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:meshHeading | pubmed-meshheading:20510551... | lld:pubmed |
| pubmed-article:20510551 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20510551 | pubmed:articleTitle | Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women. | lld:pubmed |
| pubmed-article:20510551 | pubmed:affiliation | School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. eugenia@mail.cheos.ubc.ca | lld:pubmed |
| pubmed-article:20510551 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20510551 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:20510551 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:20510551 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20510551 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20510551 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
